Veracyte, Inc. (NASDAQ: VCYT)
$43.7500
-0.0300 ( +2.97% ) 633.1K
Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against diseases such as thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis. The firm's product portfolio consists of products such as Afirma analysis, Percepta, Envisia, and others.
Market Data
Open
$43.7500
Previous close
$43.7800
Volume
633.1K
Market cap
$3.39B
Day range
$41.8020 - $43.9490
52 week range
$18.6100 - $46.0000
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Nov 21, 2024 |
4 | Insider transactions | 1 | Nov 14, 2024 |
4 | Insider transactions | 1 | Nov 14, 2024 |
10-q | Quarterly Reports | 68 | Nov 07, 2024 |
8-k | 8K-related | 15 | Nov 06, 2024 |
4 | Insider transactions | 1 | Sep 23, 2024 |
4 | Insider transactions | 1 | Sep 06, 2024 |
3 | Insider transactions | 2 | Sep 04, 2024 |
8-k | 8K-related | 13 | Sep 04, 2024 |
4 | Insider transactions | 1 | Sep 04, 2024 |